Radiolabelling of nanomaterials for medical imaging and therapy

J Pellico, PJ Gawne, RTM de Rosales - Chemical Society Reviews, 2021 - pubs.rsc.org
Nanomaterials offer unique physical, chemical and biological properties of interest for
medical imaging and therapy. Over the last two decades, there has been an increasing effort …

Molecular imaging in primary staging of prostate cancer patients: current aspects and future trends

R Manafi-Farid, S Ranjbar, Z Jamshidi Araghi, J Pilz… - Cancers, 2021 - mdpi.com
Simple Summary Accurate primary staging for determining the extent of prostate cancer is
crucial for planning treatment in high-risk patients for distant metastases. Recurrence is still …

Molecular imaging of angiogenesis in oncology: current preclinical and clinical status

A Florea, FM Mottaghy, M Bauwens - International journal of molecular …, 2021 - mdpi.com
Angiogenesis is an active process, regulating new vessel growth, and is crucial for the
survival and growth of tumours next to other complex factors in the tumour …

Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer

SY Park, SJ Na, M Kumar, C Mosci, M Wardak… - Clinical Cancer …, 2020 - AACR
Abstract Purpose:(4S)-4-(3-[18F] Fluoropropyl)-L-glutamic acid (18F-FSPG) is a
radiopharmaceutical for PET imaging of system xC− activity, which can be upregulated in …

Preclinical imaging of prostate cancer

C Olkowski, B Fernandes, GL Griffiths, F Lin… - Seminars in Nuclear …, 2023 - Elsevier
Prostate cancer remains a major cause of mortality and morbidity, affecting millions of men,
with a large percentage expected to develop the disease as they reach advanced ages …

New frontiers in molecular imaging using peptide-based radiopharmaceuticals for prostate cancer

X Li, H Cai, X Wu, L Li, H Wu, R Tian - Frontiers in Chemistry, 2020 - frontiersin.org
The high incidence of prostate cancer (PCa) increases the need for progress in its
diagnosis, staging, and precise treatment. The overexpression of tumor-specific receptors for …

Modular one-pot strategy for the synthesis of heterobivalent tracers

T Bailly, S Bodin, V Goncalves, F Denat… - ACS Medicinal …, 2023 - ACS Publications
Bivalent ligands, ie, molecules having two ligands covalently connected by a linker, have
been gathering attention since the first description of their pharmacological potential in the …

Prognostic and theranostic applications of positron emission tomography for a personalized approach to metastatic castration-resistant prostate cancer

L Filippi, V Frantellizzi, A Chiaravalloti… - International Journal of …, 2021 - mdpi.com
Metastatic castration-resistant prostate cancer (mCRPC) represents a condition of
progressive disease in spite of androgen deprivation therapy (ADT), with a broad spectrum …

Clinical advancement of precision theranostics in prostate cancer

Y Tan, Z Fang, Y Tang, K Liu, H Zhao - Frontiers in Oncology, 2023 - frontiersin.org
Theranostic approaches with positron emission tomography/computed tomography
(PET/CT) or PET/magnetic resonance imaging (PET/MRI) molecular imaging probes are …

[HTML][HTML] Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers

N Bertrand, R Mougel, G Riley, M Bruand… - International Journal of …, 2024 - mdpi.com
Neurotensin (NT) is a peptide involved in digestion, neuromodulation, and cancer
progression. NT and its receptors (NTR1 and SORT1 mainly) have been widely studied in …